NEWS
LifeSensors Headlines
Please check back often for information regarding new product releases, research goals, and important information.
LifeSensors presented an overview of ubiquitin proteomics at the 3rd GTC Conference, Ubiquitin Research and Drug Discovery, Las Vegas, February 25-26th, 2013.
Complexity of ubiquitin pathways leads to frequent questions related to identification of ubiquitin pathway enzymes (E3s and DUBs) and their substrates. An overview of biochemical proteomics for drug discovery applications including Ubiquitin Protein Microarray Services from LifeSensors was presented by Christian Loch, Assistant Director, R&D. Visit our website to find additional information about our Ubiquitin Protein Microarrays.
Visit Site >>
LifeSensors Inc. appointed 4A Biotech Co.Ltd as another distributor of its innovative reagents and technologies in China
Located at Guanglian Industrial Park, Beijing, 4A Biotech Co.Ltd. is a leading life science product provider in China.
Visit Site >>
LifeSensors presents data at FASEB's Ubiquitin & Cellular Regulation meeting June 24th-29th.
Download PDFs of poster #54 "Effect of DUB inhibitor PR-619 on the microtubule network and protein aggregate formation in oligodendroglial cells: Implications for neurodegeneration" and poster #61 "Decoding the information content of ubiquitin chains: Application of linkage-specific TUBES to the ubiquitome" from our Technical Documentation page (bottom of the page).
Visit Site >>
Human SUMO-3 Patent Expands LifeSensors' Protein Expression Portfolio
Malvern, PA, USA — March 7, 2012. LifeSensors, Inc., developer and manufacturer of SUMO-fusion technology used to overcome bottlenecks in protein production, expands its intellectual property and protein expression portfolio with its patent, “Human SUMO-3 For Enhancing Protein Expression” (US 8,119,369 B2), awarded by the United States Patent and Trademark Office last week.
Read More >>
LifeSensors Announces New Director of Sales and Marketing
Expands the Sales and Marketing team at headquarters in Malvern, PA
LifeSensors, Inc., a rapidly growing biotech company focused on developing innovative tools to facilitate protein expression and the study of the Ubiquitin Proteasome Pathway (UPP), announced today that they have appointed Dr. Mark Engleka to the position of Sales and Marketing Director.
Download PDF >>
LifeSensors Announces Bioethanol Development Collaboration with USDA, ARS
SUMO Protein Production Technology Used to Enhance Baker's Yeast Enzymes & Co-Products
MALVERN, PA. — November 29, 2011 — LifeSensors, Inc., developer of SUMO-based protein expression technologies, established a Cooperative Research and Development Agreement (CRADA) with the National Center for Agricultural Utilization Research (NCAUR) of the United States Department of Agriculture – Agricultural Research Service (ARS) in Peoria, IL.
Read More >>
Cayman Chemical Licenses LifeSensors' SUMO Platforms, Launches New Products
ANN ARBOR, MI and MALVERN, PA – November 21, 2011 – Cayman Chemical Company, Inc. and LifeSensors, Inc. signed a technology license agreement granting Cayman non-exclusive rights to LifeSensors’ protein expression technologies.
Read More >>
LifeSensors licenses SUMOpro technology to Abzyme Therapeutics
MALVERN, PA -- October 19, 2011 -- Abzyme Therapeutics, a new biotechnology company dedicated to developing methods to generate human monoclonal antibodies for the treatment of disease, announced today that they have entered into an exclusive agreement with LifeSensors to license their proprietary protein expression platform, SUMOpro™.
Download PDF >>
LifeSensors' SUMO-fusion technology
Update from PEGS 2011 meeting
MALVERN, PA – BOSTON, MA- May 25th. LifeSensors’ Protein Expression platform based on Small Ubiquitin Modifier (SUMO) fusion technology, received a lot of attention at the Seventh Annual Protein Engineering Summit (PEGS) May 9-13, 2011 in Boston, MA.
Read More >>
LifeSensors Launches DiUbiquitin Substrate
A Novel Fluorescent Assay for Ubiquitin Isopeptide Bond Cleavage
MALVERN, PA -- June 29, 2010 --LifeSensors, Inc., a biotechnology company, announces the launch of its novel physiologically relevant diubiquitin substrates for measuring isopeptide bond cleavage (patent applied for). This breakthrough technology, for both basic research and drug discovery targeting the ubiquitin proteasome pathway, offers sensitive, rapid, and robust fluorescent readouts of isopeptidase or de-ubquitylase (DUB) activity.
Visit Site >>
LifeSensors' Gender Sorting Technology Discussed
Feb 9th 2010 | From The Economist online
Dr Butt’s new device is an oestrogen sniffer. It relies on the fact that female embryos produce this hormone in quantity and male ones do not. The sensor uses a fine needle to penetrate both the shell and the allantoic sac of an egg. This sac is a fluid-filled membrane that cushions the embryo and helps it trade carbon dioxide for oxygen from the air. (It is also the membrane that can make peeling a hard-boiled egg such a frustrating affair.)
Visit Site >>
LifeSensors Publishes in Journal of Animal Science
2010 Jan 15.
An estrogen sensor for poultry gender sorting.
Tran HT, Ferrell W, Butt TR.
The need for segregation of poultry based on sex is driven by gender-related differences in growth rate, market age, management practices, and nutritional requirements. Each day, global poultry industry staff would ideally like to determine the gender of >150 million newly hatched birds. Currently, this can be done only manually at the hatchery, which is a virtually impossible undertaking. LifeSensors has developed a facile, rapid, and low cost yeast-based assay that distinguishes male from female embryonated eggs before hatching based on the estrogen level of their allantoic fluid.
Visit Site >>
LifeSensors Launches New Website
LifeSensors launched its new website on October 9th, 2009. The new site will allow researchers all over the world to learn more about what has made LifeSensors' SUMO fusion technologies and novel ubiquitin research tools successful.
Read More >>
LifeSensors, Inc. Sponsors Ubiquitin Drug Discovery and Diagnostics 2009
Date: October, 13 - 14, 2009
The ubiquitin story has launched an exciting new enterprise in molecular medicine. The 2004 Nobel Prize in Chemistry was awarded to Dr. Aaron Ciechanover and colleagues for uncovering the ubiquitin pathway, which we now know plays a fundamental role in human physiology
Visit Site >>
LifeSensors, Inc. Obtains Worldwide, Exclusive License to High Affinity Ubiquitin Traps
Press Release
Visit Site >>
LifeSensors, Inc. Signs Distribution Agreement with Nacalai USA, Inc.
Press Release
Visit Site >>
LifeSensors, Inc. Launches their Ubiquitin Pathway Enzymes Assay Kits Licensed from Progenra, Inc.
Press Release
Visit Site >>
